Company · CIK 1532346
Atreca, Inc.
Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26
| CIK | 1532346 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-08-13 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-239654 | 2020-07-02 | 2024-03-22 | 4 | |
| 333-273314 | 2023-07-18 | 2024-03-22 | 3 | |
| 333-239652 | 2020-07-02 | 2020-08-12 | 5 | |
| 333-231770 | 2019-05-24 | 2019-06-20 | 4 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-03-22 | EFFECTDeclared effective | 333-273314 | 9999999995-24-000710 |
| 2024-03-22 | EFFECTDeclared effective | 333-239654 | 9999999995-24-000708 |
| 2023-08-17 | EFFECTDeclared effective | 333-273314 | 9999999995-23-002431 |
| 2023-07-18 | S-3Shelf registered | 333-273314 | 0001104659-23-082074 |
| 2020-08-12 | 424B5Shelf takedown | 333-239652 | 0001047469-20-004549 |
| 2020-08-12 | 424B5Shelf takedown | 333-239654 | 0001047469-20-004545 |
| 2020-07-17 | 424B5Shelf takedown | 333-239652 | 0001047469-20-004130 |
| 2020-07-15 | 424B5Shelf takedown | 333-239652 | 0001047469-20-004105 |
| 2020-07-10 | EFFECTDeclared effective | 333-239654 | 9999999995-20-001772 |
| 2020-07-10 | EFFECTDeclared effective | 333-239652 | 9999999995-20-001771 |
| 2020-07-02 | S-3Shelf registered | 333-239654 | 0001047469-20-003956 |
| 2020-07-02 | S-3Shelf registered | 333-239652 | 0001047469-20-003954 |
| 2019-06-20 | 424B4Final prospectus | 333-231770 | 0001047469-19-003758 |
| 2019-06-19 | EFFECTDeclared effective | 333-231770 | 9999999995-19-001380 |
| 2019-06-10 | S-1/AAmendment | 333-231770 | 0001410578-19-000304 |
| 2019-05-24 | S-1Registration filed | 333-231770 | 0001047469-19-003318 |
| 2019-04-24 | DRSDraft made public | 377-02606 | 0000912057-19-000172 |